obp Surgical

Canaccord Genuity Acts as Financial Advisor to obp Surgical Corporation on its Sale to CooperSurgical, Inc.

Canaccord Genuity is pleased to announce that on August 1, 2024, obp Surgical Corporation (“obp”), a medical device company with a suite of single-use surgical retractors and suction devices, has been acquired by CooperSurgical, Inc., a subsidiary of Cooper Companies, Inc. (Nasdaq: COO) focused on developing fertility and women’s healthcare solutions. According to the terms of the deal, CooperSurgical will acquire obp for approximately $100 million in cash.

Canaccord Genuity acted as financial advisor to obp in connection with the transaction.

obp develops a suite of next-generation, single-use cordless surgical retractors and suction devices with integrated illumination and smoke evacuation that maximize clinical efficiency and functionality for healthcare providers and improve outcomes for patients. obp’s products are used in surgery centers and hospital operating rooms throughout the United States and worldwide. obp was created in a spin-off from its predecessor company, obp Medical Corporation, after that company was acquired by CooperSurgical in May 2021. 

CooperSurgical, Inc. is a leading fertility and women's healthcare company dedicated to putting time on the side of women, babies and families at the healthcare moments that matter most in life. CooperSurgical, Inc. is a wholly-owned subsidiary of Cooper Companies, Inc. (Nasdaq: COO), a publicly-held global medical device company.

Canaccord Genuity is focused on the corporate finance needs associated with growth companies in the United States, Canada, Europe and Asia. We are structured to provide our clients with a full range of global investment banking services, including corporate finance, research, sales and trading. Our thematic research focusing on companies around the world provides our firm with unique access to growth investors. In the last twelve months, the firm advised on approximately 100 M&A assignments globally.